Advanced Search
Submit Manuscript Volume 30, No 11, Nov 2020
ISSN: 1001-0602
EISSN: 1748-7838 2018
impact factor 17.848*
(Clarivate Analytics, 2019)
Volume 30 Issue 11, November 2020: 1024-1042 |
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
Yu-Pei Chen1,† , Jian-Hua Yin2,† , Wen-Fei Li1,† , Han-Jie Li3,† , Dong-Ping Chen1,4,† , Cui-Juan Zhang2,† , Jia-Wei Lv1 , Ya-Qin Wang1 , Xiao-Min Li1 , Jun-Yan Li1 , Pan-Pan Zhang1 , Ying-Qin Li1 , Qing-Mei He1 , Xiao-Jing Yang1 , Yuan Lei1 , Ling-Long Tang1 , Guan-Qun Zhou1 , Yan-Ping Mao1 , Chen Wei2 , Ke-Xu Xiong2 , Hong-Bo Zhang5 , Shi-Da Zhu2 , Yong Hou2 , Ying Sun1 , Michael Dean6 , Ido Amit7 , Kui Wu2 , Dong-Ming Kuang1,4 , Gui-Bo Li2,8 , Na Liu1 , Jun Ma1,*
1Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, ChinaNasopharyngeal carcinoma (NPC) is an aggressive malignancy with extremely skewed ethnic and geographic distributions. Increasing evidence indicates that targeting the tumor microenvironment (TME) represents a promising therapeutic approach in NPC, highlighting an urgent need to deepen the understanding of the complex NPC TME. Here, we generated single-cell transcriptome profiles for 7581 malignant cells and 40,285 immune cells from fifteen primary NPC tumors and one normal sample. We revealed malignant signatures capturing intratumoral transcriptional heterogeneity and predicting aggressiveness of malignant cells. Diverse immune cell subtypes were identified, including novel subtypes such as CLEC9A+ dendritic cells (DCs). We further revealed transcriptional regulators underlying immune cell diversity, and cell–cell interaction analyses highlighted promising immunotherapeutic targets in NPC. Moreover, we established the immune subtype-specific signatures, and demonstrated that the signatures of macrophages, plasmacytoid dendritic cells (pDCs), CLEC9A+ DCs, natural killer (NK) cells, and plasma cells were significantly associated with improved survival outcomes in NPC. Taken together, our findings represent a unique resource providing in-depth insights into the cellular heterogeneity of NPC TME and highlight potential biomarkers for anticancer treatment and risk stratification, laying a new foundation for precision therapies in NPC.
https://doi.org/10.1038/s41422-020-0374-x